AMPIO PHARMS INC by Ampio Pharmaceuticals, Inc. Financials - Benzinga

AMPIO PHARMS INC by Ampio Pharmaceuticals, Inc.

AMPEOTCEM

Trade with Public

Trade with Public

$0.1831

-0.44-70.47%

Last update: May 8, 10:35 AM

Overview News Earnings ForecastFinancialsSentiment Ownership Compare

AMPIO PHARMS INC by Ampio Pharmaceuticals, Inc. Financials

AMPIO PHARMS INC by Ampio Pharmaceuticals, Inc. (AMPE) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Ampio Pharmaceuticals Q4 EPS $(2.48) Up From $(3.60) YoY

Ampio Pharmaceuticals (AMEX:AMPE) reported quarterly losses of $(2.48) per share. This is a 31.11 percent increase over losses of $(3.60) per share from the same period last year.

Happy Mohamed

US Stocks Mixed; Dell Posts Weak Sales

U.S. stocks traded mixed this morning, with the Dow Jones index gaining over 80 points on Friday. Following the market opening Friday, the Dow traded up 0.23% to 36,033.47 while the NASDAQ fell 0.20% to 14,197.42. The S&P 500 also rose, gaining, 0.05% to 4,570.08.

Lisa Levin

US Stocks Mixed; Pfizer Earnings Beat Views

U.S. stocks were mixed this morning, with the Dow Jones trading slightly higher on Tuesday. Following the market opening Tuesday, the Dow traded up 0.03% to 35,568.68 while the NASDAQ fell 0.57% to 14,264.52. The S&P 500, also fell, dropping, 0.32% to 4,574.50.

Lisa Levin

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.

Lisa Levin

The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

Ampio Pharmaceuticals: Q1 Earnings Insights

Ampio Pharmaceuticals (AMEX:AMPE) reported its Q1 earnings results on Monday, May 16, 2022 at 04:10 PM. Here's what investors need to know about the announcement.

Benzinga Insights